Zhenrong Tang Selected Research

Breast Neoplasms (Breast Cancer)

1/2023	The impact of postmastectomy radiotherapy on cT1-2N1 breast cancer patients with ypN0 after neoadjuvant chemotherapy: a retrospective study based on real-world data.
1/2023	A mitochondrial function-related LncRNA signature predicts prognosis and immune microenvironment for breast cancer.
12/2022	Comprehensive Analysis of Necroptosis-Related Genes as Prognostic Factors and Immunological Biomarkers in Breast Cancer.
12/2022	Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy.
9/2022	MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer.
5/2022	Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy.
1/2022	Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer.
1/2022	Association of serum reproductive hormones changes after neoadjuvant chemotherapy with hormone receptors expression alterations and survival outcomes in breast cancer.
5/2021	Plasma fibrinogen acts as a predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer: a retrospective study of 1004 Chinese breast cancer patients.
2/2021	Treatment response correlation between primary tumor and axillary lymph nodes after neoadjuvant therapy in breast cancer: a retrospective study based on real-world data.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenrong Tang Research Topics

Disease

15	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2018
7	Neoplasms (Cancer) 01/2023 - 07/2018
1	Starvation 08/2023
1	Inflammatory Breast Neoplasms 12/2022
1	Carcinogenesis 09/2022
1	Infections 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Pathologic Complete Response 02/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Lymphatic Metastasis 12/2020
1	Neoplasm Metastasis (Metastasis) 09/2018
1	Hepatocellular Carcinoma (Hepatoma) 09/2018

Drug/Important Bio-Agent (IBA)

3	Hormones (Hormone)IBA 05/2022 - 02/2021
3	Phenobarbital (Luminal)FDA Link 01/2021 - 07/2018
2	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2022
2	Long Noncoding RNAIBA 01/2023 - 09/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2018
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
1	Immune Checkpoint ProteinsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	Coloring Agents (Dyes)IBA 12/2022
1	Mediator ComplexIBA 09/2022
1	Tamoxifen FDA LinkGeneric 09/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	SolutionsIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 05/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2021
1	human ERBB2 proteinIBA 12/2020
1	LigandsIBA 12/2020
1	Ki-67 Antigen (Ki 67 Antigen)IBA 12/2020
1	Estrogen ReceptorsIBA 12/2020
1	LipidsIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	RNA-Induced Silencing ComplexIBA 09/2018
1	LuciferasesIBA 09/2018

Therapy/Procedure

10	Neoadjuvant Therapy 01/2023 - 07/2018
3	Therapeutics 05/2022 - 07/2018
1	Radiotherapy 01/2023
1	Simple Mastectomy 01/2023
1	Immunotherapy 01/2022